LifeWatch AG
LifeWatch AG: LOI with GE Healthcare to develop strategic relationship signed
EQS Group-Ad-hoc: LifeWatch AG / Key word(s): Letter of Intent LifeWatch signs LOI with GE Healthcare to develop strategic relationship Zug/Switzerland, October 24, 2016 – LifeWatch AG (SIX Swiss Exchange: LIFE), a leading developer and provider of medical solutions and remote diagnostic monitoring services in the digital health market, announces that the company has signed a Letter of Intent (LOI) with GE Medical Systems Information Technologies, Inc., a Wisconsin corporation doing business as GE Healthcare, along with its affiliates (GE Healthcare). The purpose of the LOI is to explore the opportunities of a long-term strategic relationship regarding the exclusive third-party distribution of LifeWatch’s monitoring services in the USA and possible other markets as well as other potential ventures. This LOI is non-binding and the intended relationship is subject to the signing of a definitive cooperation agreement. About LifeWatch AG LifeWatch AG, headquartered in Zug and listed on SIX Swiss Exchange (LIFE), Switzerland, is a leading healthcare technology and solution company, specializing in advanced digital health systems and wireless remote diagnostic patient monitoring services. LifeWatch’s services provide physicians with critical information to determine appropriate treatment and thereby improve patient outcomes. LifeWatch AG has operative subsidiaries in the United States, in Switzerland and in Israel, and is the parent company of LifeWatch Services Inc., and LifeWatch Technologies, Ltd. LifeWatch Services, Inc. is a leading U.S.-based provider of cardiac monitoring services. LifeWatch Technologies Ltd., based in Israel, is a leading developer and manufacturer of telemedicine products. For additional information, please visit www.lifewatch.com. Sign up for customized e-mail alerts and documentation requests at
THIS PRESS RELEASE IS NOT BEING ISSUED IN THE UNITED STATES OF AMERICA AND MUST NOT BE DISTRIBUTED TO UNITED STATES PERSONS OR PUBLICATIONS WITH A GENERAL CIRCULATION IN THE UNITED STATES. THIS PRESS RELEASE DOES NOT CONSTITUTE AN OFFER OF SECURITIES OF LIFEWATCH AG OR ANY OF ITS SUBSIDIARIES FOR SALE IN THE UNITED STATES, OR AN INVITATION TO SUBSCRIBE FOR OR PURCHASE ANY SECURITIES OF LIFEWATCH AG OR ITS SUBSIDIARIES IN THE UNITED STATES. IN ADDITION, THE SECURITIES OF LIFEWATCH AG AND ITS SUBSIDIARIES HAVE NOT BEEN REGISTERED UNDER THE UNITED STATES SECURITIES LAWS AND MAY NOT BE OFFERED, SOLD OR DELIVERED WITHIN THE UNITED STATES OR TO U.S. PERSONS ABSENT FROM REGISTRATION UNDER OR AN APPLICABLE EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE UNITED STATES SECURITIES LAWS. Additional features: Document: http://n.eqs.com/c/fncls.ssp?u=VCJULDUWEP Document title: LifeWatch signs LOI with GE Healthcare to develop strategic relationship End of ad hoc announcement |
Language: | English | |
Company: | LifeWatch AG | |
Baarerstrasse 139 | ||
6300 Zug | ||
Switzerland | ||
Phone: | +41 41 728 67 78 | |
Internet: | www.lifewatch.com | |
ISIN: | CH0012815459 | |
Valor: | 811189 | |
Listed: | Regulated Unofficial Market in Berlin, Stuttgart; Open Market in Frankfurt ; SIX Swiss Exchange | |
End of News | EQS Group News Service |